{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:37:04Z","timestamp":1789011424345,"version":"build-2803163510"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10,1]]},"DOI":"10.1093\/jac\/dkh412","type":"journal-article","created":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T20:25:06Z","timestamp":1095366306000},"page":"836-839","source":"Crossref","is-referenced-by-count":21,"title":["Tissue and serum levofloxacin concentrations in diabetic foot infection patients"],"prefix":"10.1093","volume":"54","author":[{"given":"K.","family":"Oberdorfer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Baertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kusterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hoppe-Tichy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. K.","family":"Geiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"von Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,10]]},"reference":[{"key":"key\n\t\t\t\t20171010174419_R1","doi-asserted-by":"crossref","unstructured":"Boulton, A. J., Meneses, P. & Ennis, W. J. (1999). Diabetic foot ulcers: a framework for prevention and care. Wound Repair and Regeneration7, 7\u201316.","DOI":"10.1046\/j.1524-475X.1999.00007.x"},{"key":"key\n\t\t\t\t20171010174419_R2","doi-asserted-by":"crossref","unstructured":"Louie, T. J., Bartlett, J. G., Tally, F. P. et al. (1976). Aerobic and anaerobic bacteria in diabetic foot ulcers. Annals of Internal Medicine85, 461\u20133.","DOI":"10.7326\/0003-4819-85-4-461"},{"key":"key\n\t\t\t\t20171010174419_R3","doi-asserted-by":"crossref","unstructured":"Fish, D. N. & Chow, A. T. (1997). The clinical pharmocokinetics of levofloxacin. Clinical Pharmacokinetics32, 101\u201319.","DOI":"10.2165\/00003088-199732020-00002"},{"key":"key\n\t\t\t\t20171010174419_R4","doi-asserted-by":"crossref","unstructured":"Wagner, F. W. Jr (1981). The dysvascular foot: a system of diagnosis and treatment. Foot & Ankle2, 64\u2013122.","DOI":"10.1177\/107110078100200202"},{"key":"key\n\t\t\t\t20171010174419_R5","doi-asserted-by":"crossref","unstructured":"Boettcher, S., von Baum, H., Hoppe-Tichy, T. et al. (2001). An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. Journal of Pharmaceutical and Biomedical Analysis25, 197\u2013203.","DOI":"10.1016\/S0731-7085(00)00478-7"},{"key":"key\n\t\t\t\t20171010174419_R6","doi-asserted-by":"crossref","unstructured":"Swoboda, S., Oberdorfer, K., Klee, F. et al. (2003). Tissue and serum concentration of levofloxacin 500\u2009mg administered intravenously or orally for antibiotic prophylaxis in biliary surgery. Journal of Antimicrobial Chemotherapy51, 459\u201362.","DOI":"10.1093\/jac\/dgk056"},{"key":"key\n\t\t\t\t20171010174419_R7","doi-asserted-by":"crossref","unstructured":"Kuck, E. M., Bouter, K. P., Hoekstra, J. B. et al. (1998). Tissue concentrations after a single-dose, orally administered ofloxacin in patients with diabetic foot infections. Foot & Ankle International19, 38\u201340.","DOI":"10.1177\/107110079801900107"},{"key":"key\n\t\t\t\t20171010174419_R8","unstructured":"Mueller-Buehl, U., Diehm, C., Gutzler, F. et al. (1991). Tissue concentrations of ofloxacin in necrotic foot lesions of diabetic and non-diabetic patients with peripheral arterial occlusive disease. Vasa20, 17\u201321."},{"key":"key\n\t\t\t\t20171010174419_R9","doi-asserted-by":"crossref","unstructured":"Chow, A. T., Chen, A., Lattime, H. et al. (2002). Penetration of levofloxacin into skin tissue after oral administration of multiple 750\u2009mg once-daily doses. Journal of Clinical Pharmacy and Therapeutics27, 143\u201350.","DOI":"10.1046\/j.1365-2710.2002.00396.x"},{"key":"key\n\t\t\t\t20171010174419_R10","doi-asserted-by":"crossref","unstructured":"Lipsky, B. A., Bakter, P. D., Landon, G. C. et al. (1997). Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clinical Infectious Diseases24, 643\u20138.","DOI":"10.1093\/clind\/24.4.643"},{"key":"key\n\t\t\t\t20171010174419_R11","doi-asserted-by":"crossref","unstructured":"Graham, D. R., Talan, D. A., Nichols, R. L. et al. (2002). Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxycillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial. Clinical Infectious Disease35, 381\u20139.","DOI":"10.1086\/341026"},{"key":"key\n\t\t\t\t20171010174419_R12","doi-asserted-by":"crossref","unstructured":"Weber, S., Gold, H. S., Hooper, D. C. et al. (2003). Fluoroquinolones and the risk for Methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerging Infectious Diseases9, 1415\u201321.","DOI":"10.3201\/eid0911.030284"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/54\/4\/836\/2294605\/dkh412.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T20:19:29Z","timestamp":1507666769000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/54\/4\/836\/763471\/Tissue-and-serum-levofloxacin-concentrations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,1]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,10]]},"published-print":{"date-parts":[[2004,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh412","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10]]},"published":{"date-parts":[[2004,10,1]]}}}